September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 09, 2025

Merger Cure? Rural Hospitals Try Networks

Mobile magnetic resonance imaging units and rural hospital networks support independent hospitals in improving access to diagnostic imaging and patient care in underserved areas.

KFF Health News

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant

September 05, 2025

Review Finds Misdiagnosis and Referral Delays in Endometriosis

Symptom dismissal, misdiagnosis, and long waits for referral contribute to delays in diagnosis and treatment.

Conexiant

September 04, 2025

Genetic and Environmental Factors Drive Spina Bifida Risk

Emerging evidence shows how maternal health, environmental exposures, and genetic variants interact to affect neural tube development.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 22, 2025

Linear Hyperpigmentation After Chemotherapy: What's Your Diagnosis?

A 15-year-old girl developed distinctive, painless, whip-like streaks across her trunk and back after receiving combination chemotherapy for ovarian yolk sac tumor. What’s your diagnosis?

Conexiant

August 22, 2025

Mortality in Advanced-Stage Ovarian Cancer—Effect of Neoadjuvant Chemotherapy and Cytoreductive Surgery Case Volume

In a cross-sectional study reported in JAMA Network Open, Abel et al found that higher rates of neoadjuvant chemotherapy and a higher annual volume of cytoreductive surgery were associated with better...

The ASCO Post

August 20, 2025

USO Tied to Lower HGSC Risk, Study Shows

Researchers assess whether unilateral salpingo-oophorectomy before age 50 lowers cancer risk without raising cardiovascular or bone complications.

Conexiant